The first commitment will be £40 million for the creation of up to five Translational Rare Disease Centres across the UK to help pioneer new diagnostic approaches and treatments.

LifeArc, the self-funded, non-profit medical research organisation and charity, has launched a new programme that will look to invest more than £100 million by 2030 to deliver new breakthroughs to improve the lives of people living with a rare disease. The groundbreaking Rare Disease Translational Challenge will bring together researchers in rare disease with the expertise LifeArc can offer in…